Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lopalco

Showing results (171-180 of 221) with videos related to

Pageof 23
Sort By:
Frontiers in Pharmacology|November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Ophthalmology and Therapy|January 29, 2022
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious ScleritisFrancesca Della Casa, Antonio Vitale, Rosa Maria Pereira, et al.
Clinical & Experimental Ophthalmology|April 4, 2025
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis RegistryCarla Gaggiano, Alejandra de-la-Torre, Silvana Guerriero, et al.
Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.
Frontiers in Medicine|March 11, 2020
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory OutcomesAntonio Vitale, Giulio Cavalli, Piero Ruscitti, et al.
Frontiers in Immunology|July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registryJurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Clinical Rheumatology|May 18, 2018
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyJurgen Sota, Antonio Vitale, Antonella Insalaco, et al.
Ophthalmology and Therapy|January 31, 2022
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious UveitisFrancesca Della Casa, Antonio Vitale, Silvana Guerriero, et al.
Internal and Emergency Medicine|October 6, 2023
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease RegistryMartina D'Onghia, Elisa Cinotti, Alessandra Cartocci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 23

Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Frontiers in Pharmacology|November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Ophthalmology and Therapy|January 29, 2022
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious ScleritisFrancesca Della Casa, Antonio Vitale, Rosa Maria Pereira, et al.
Clinical & Experimental Ophthalmology|April 4, 2025
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis RegistryCarla Gaggiano, Alejandra de-la-Torre, Silvana Guerriero, et al.
Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.
Frontiers in Medicine|March 11, 2020
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory OutcomesAntonio Vitale, Giulio Cavalli, Piero Ruscitti, et al.
Frontiers in Immunology|July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registryJurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Clinical Rheumatology|May 18, 2018
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyJurgen Sota, Antonio Vitale, Antonella Insalaco, et al.
Ophthalmology and Therapy|January 31, 2022
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious UveitisFrancesca Della Casa, Antonio Vitale, Silvana Guerriero, et al.
Internal and Emergency Medicine|October 6, 2023
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease RegistryMartina D'Onghia, Elisa Cinotti, Alessandra Cartocci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 23